Literature DB >> 24271520

Saturable processes affecting renal clearance of cefixime in dogs.

A P Tonelli1, M Bialer, Z M Look, S Carson, A Yacobi.   

Abstract

The pharmacokinetics of cefixime, a new orally active cephalosporin, was studied after an intravenous dose of 50 mg/kg to four beagle dogs. Cefixime was shown to exhibit concentration dependent serum protein binding and saturable tubular reabsorption. The drug was excreted mainly in the urine, the net result of glomerular filtration and saturable tubular reabsorption. The experimental results were analyzed by model independent pharmacokinetic equations and with theoretical models describing renal clearance. Modification of the models, based on observed data, was proposed. The experimental methods employed and the pharmacokinetic approach offered in this study can be applied to drugs that exhibit concentration dependent protein binding and saturable renal elimination processes.

Entities:  

Year:  1986        PMID: 24271520     DOI: 10.1023/A:1016309923717

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  Errors in interpretation of data from equilibrium dialysis protein binding experiments.

Authors:  H L Behm; J G Wagner
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1979-10

2.  Determination of a new orally active cephalosporin in human plasma and urine by high-performance liquid chromatography using automated column switching.

Authors:  Y Tokuma; Y Shiozaki; H Noguchi
Journal:  J Chromatogr       Date:  1984-11-28

3.  Pharmacokinetics and clearances related to renal processes.

Authors:  E R Garrett
Journal:  Int J Clin Pharmacol Biopharm       Date:  1978-04

4.  Relationship between protein binding and renal clearance of a new oral cephalosporin in the dog.

Authors:  A P Tonelli; M Bialer; A Yacobi
Journal:  J Pharm Sci       Date:  1985-11       Impact factor: 3.534

5.  Effect of plasma protein binding on renal clearance of drugs.

Authors:  G Levy
Journal:  J Pharm Sci       Date:  1980-04       Impact factor: 3.534

6.  Mechanism of action of the new orally active cephalosporin FK027.

Authors:  Y Shigi; Y Matsumoto; M Kaizu; Y Fujishita; H Kojo
Journal:  J Antibiot (Tokyo)       Date:  1984-07       Impact factor: 2.649

7.  Effect of serum protein binding on sulfisoxazole distribution, metabolism, and excretion in rats.

Authors:  A Yacobi; G Levy
Journal:  J Pharm Sci       Date:  1979-06       Impact factor: 3.534

8.  Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics.

Authors:  K Stoeckel; P J McNamara; R Brandt; H Plozza-Nottebrock; W H Ziegler
Journal:  Clin Pharmacol Ther       Date:  1981-05       Impact factor: 6.875

9.  Pharmacokinetics of FK027 in rats and dogs.

Authors:  H Sakamoto; T Hirose; Y Mine
Journal:  J Antibiot (Tokyo)       Date:  1985-04       Impact factor: 2.649

10.  In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic.

Authors:  T Kamimura; H Kojo; Y Matsumoto; Y Mine; S Goto; S Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.